Replies to post #1515 on Idera Pharmaceuticals Inc (IDRA)

[binchey]

Executives should be able to get at least monthly updates due to the nature of ongoing trials (WM + DLBCL)

Hence, I hope Vince will provide some color tomorrow. Yes, I will be listening very very carefully ;-)